![](https://scx1.b-cdn.net/csz/news/tmb/2021/heart-model-1.jpg)
Adults with acute heart failure benefit when treated with empagliflozin, a type 2 diabetes medication
Adults treated with empagliflozin during hospitalization for acute heart failure experienced a clinical benefit such as increased survival, lower risk of heart failure hospital readmission and an overall improvement in their ...
Nov 15, 2021
0
3